Skip to main navigation Skip to search Skip to main content

Phase I dose escalation study of procaspase-activating compound-1 (PAC-1) in combination with temozolomide in patients with recurrent high-grade astrocytomas

  • Matthias Holdhoff
  • , M Kelly Nicholas
  • , Richard a Peterson
  • , Stefania Maraka
  • , Li C. Liu
  • , James H Fischer
  • , Jeffrey S Wefel
  • , Timothy M Fan
  • , Tracy Vannorsdall
  • , Meredith Russell
  • , Michaella Iacoboni
  • , Theodore M Tarasow
  • , Paul J Hergenrother
  • , Arkadiusz Z Dudek
  • , Oana C Danciu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I dose escalation study of procaspase-activating compound-1 (PAC-1) in combination with temozolomide in patients with recurrent high-grade astrocytomas'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science